Researchers will determine the optimal intravenous and intra-articular dosing protocol for amikacin, an antibiotic used to treat bacterial infections in foals.

Researchers will manipulate the expression of immune markers on stem cells to develop safer and more effective therapies for horses with musculoskeletal injuries.

Researchers will investigate the mechanisms leading to development and transmission of antimicrobial resistance in Rhodococcus equi, a bacterial agent that causes severe pneumonia in foals.

Researchers will investigate a new strategy to improve treatment of persistent joint infections that cause inflammation and osteoarthritis in horses.

Researchers will investigate differences in mast cell subtypes found in the airways of heathy and asthmatic horses to help identify better diagnostic and treatment strategies for equine asthma.